These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34007047)

  • 21. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.
    Wolff F; Dahma H; Duterme C; Van den Wijngaert S; Vandenberg O; Cotton F; Montesinos I
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115140. PubMed ID: 32829098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    Tuaillon E; Bolloré K; Pisoni A; Debiesse S; Renault C; Marie S; Groc S; Niels C; Pansu N; Dupuy AM; Morquin D; Foulongne V; Bourdin A; Le Moing V; Van de Perre P
    J Infect; 2020 Aug; 81(2):e39-e45. PubMed ID: 32504735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
    Gallais F; Velay A; Nazon C; Wendling MJ; Partisani M; Sibilia J; Candon S; Fafi-Kremer S
    Emerg Infect Dis; 2021 Jan; 27(1):113-21. PubMed ID: 33261718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroconversion Rate and Diagnostic Accuracy of Serological Tests for Coronavirus 2019.
    Nagappa B; Marimuthu Y
    Clin Infect Dis; 2020 Dec; 71(11):3016. PubMed ID: 32472684
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission.
    Borges V; Isidro J; Macedo F; Neves J; Silva L; Paiva M; Barata J; Catarino J; Ciobanu L; Duarte S; Vieira L; Guiomar R; Gomes JP
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
    Mellinghoff SC; Robrecht S; Mayer L; Weskamm LM; Dahlke C; Gruell H; Vanshylla K; Schlösser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
    Leukemia; 2022 Feb; 36(2):562-565. PubMed ID: 34937858
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
    Zhao J; Yuan Q; Wang H; Liu W; Liao X; Su Y; Wang X; Yuan J; Li T; Li J; Qian S; Hong C; Wang F; Liu Y; Wang Z; He Q; Li Z; He B; Zhang T; Fu Y; Ge S; Liu L; Zhang J; Xia N; Zhang Z
    Clin Infect Dis; 2020 Nov; 71(16):2027-2034. PubMed ID: 32221519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure and seroconversion to severe acute respiratory syndrome coronavirus 2 among obstetrical healthcare providers following a contained outbreak.
    Kiefer MK; McKiever ME; Russo JR; Ma'ayeh M; Gee SE; Smith DD; Kniss DA; Cackovic M; Costantine MM; Landon MB; Rood KM
    Am J Obstet Gynecol; 2020 Oct; 223(4):601-603.e2. PubMed ID: 32553914
    [No Abstract]   [Full Text] [Related]  

  • 34. Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak.
    Donadio C; Rainone A; Gouronnec A; Belmin J; Lafuente-Lafuente C
    J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33852930
    [No Abstract]   [Full Text] [Related]  

  • 35. A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study.
    Zamberg I; Manzano S; Posfay-Barbe K; Windisch O; Agoritsas T; Schiffer E
    JMIR Public Health Surveill; 2020 Apr; 6(2):e18668. PubMed ID: 32250958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.
    Gheorghe AS; Negru ŞM; Nițipir C; Mazilu L; Marinca M; Gafton B; Ciuleanu TE; Schenker M; Dragomir RD; Gheorghe AD; Stovicek PO; Bandi-Vasilica M; Boț AC; Mihăilă RI; Zob DL; Kajanto AL; Stănculeanu DL
    ESMO Open; 2021 Feb; 6(1):100027. PubMed ID: 33399089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Danish hospital outbreak of SARS-CoV-2. Combining whole-genome sequencing with epidemiological links offers surprising new information.
    Olesen B; Hansen TA; Hansen VM; Gyrup HB; Marloth T; Nielsen L
    J Hosp Infect; 2021 Nov; 117():188-189. PubMed ID: 34425142
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.
    Lin YC; Cheng CY; Chen CP; Cheng SH; Chang SY; Hsueh PR
    Int J Infect Dis; 2020 Jul; 96():464-466. PubMed ID: 32470604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit.
    Hains DS; Schwaderer AL; Carroll AE; Starr MC; Wilson AC; Amanat F; Krammer F
    JAMA; 2020 Jun; 323(23):2424-2425. PubMed ID: 32407440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.